Go Pro

Elevance Health (ELV) Competitors

Elevance Health logo
$407.05 -7.73 (-1.86%)
As of 09/4/2026 03:58 PM Eastern

ELV vs. CNC, MOH, UNH, HUM, and OSCR

Should you buy Elevance Health stock or one of its competitors? Elevance Health's main competitors and comparable companies include Centene (CNC), Molina Healthcare (MOH), UnitedHealth Group (UNH), Humana (HUM), and Oscar Health (OSCR). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "managed healthcare" industry.

How does Elevance Health compare to Centene?

Centene (NYSE:CNC) and Elevance Health (NYSE:ELV) are both large-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, media sentiment, profitability, risk, analyst recommendations, dividends, institutional ownership and valuation.

Elevance Health has a net margin of 2.47% compared to Centene's net margin of -2.51%. Elevance Health's return on equity of 14.64% beat Centene's return on equity.

Company Net Margins Return on Equity Return on Assets
Centene-2.51% 12.12% 3.20%
Elevance Health 2.47%14.64%5.22%

Centene has a beta of 1.1, meaning that its stock price is 10% more volatile than the broader market. Comparatively, Elevance Health has a beta of 0.69, meaning that its stock price is 31% less volatile than the broader market.

Elevance Health has higher revenue and earnings than Centene. Centene is trading at a lower price-to-earnings ratio than Elevance Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Centene$194.78B0.17-$6.67B-$10.44N/A
Elevance Health$201.11B0.44$5.66B$22.5018.09

In the previous week, Centene had 4 more articles in the media than Elevance Health. MarketBeat recorded 20 mentions for Centene and 16 mentions for Elevance Health. Elevance Health's average media sentiment score of 1.60 beat Centene's score of 1.19 indicating that Elevance Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Centene
13 Very Positive mention(s)
1 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Elevance Health
15 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

93.6% of Centene shares are owned by institutional investors. Comparatively, 89.2% of Elevance Health shares are owned by institutional investors. 0.4% of Centene shares are owned by insiders. Comparatively, 0.3% of Elevance Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Centene presently has a consensus target price of $70.05, indicating a potential upside of 4.68%. Elevance Health has a consensus target price of $440.90, indicating a potential upside of 8.32%. Given Elevance Health's stronger consensus rating and higher probable upside, analysts plainly believe Elevance Health is more favorable than Centene.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Centene
2 Sell rating(s)
9 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.40
Elevance Health
0 Sell rating(s)
8 Hold rating(s)
15 Buy rating(s)
0 Strong Buy rating(s)
2.65

Summary

Elevance Health beats Centene on 12 of the 17 factors compared between the two stocks.

How does Elevance Health compare to Molina Healthcare?

Molina Healthcare (NYSE:MOH) and Elevance Health (NYSE:ELV) are both large-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, valuation, dividends, profitability, risk, analyst recommendations, institutional ownership and media sentiment.

Elevance Health has a net margin of 2.47% compared to Molina Healthcare's net margin of -0.02%. Elevance Health's return on equity of 14.64% beat Molina Healthcare's return on equity.

Company Net Margins Return on Equity Return on Assets
Molina Healthcare-0.02% 3.73% 0.97%
Elevance Health 2.47%14.64%5.22%

Elevance Health has higher revenue and earnings than Molina Healthcare. Molina Healthcare is trading at a lower price-to-earnings ratio than Elevance Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Molina Healthcare$45.43B0.23$472M-$0.18N/A
Elevance Health$201.11B0.44$5.66B$22.5018.09

98.5% of Molina Healthcare shares are owned by institutional investors. Comparatively, 89.2% of Elevance Health shares are owned by institutional investors. 1.4% of Molina Healthcare shares are owned by company insiders. Comparatively, 0.3% of Elevance Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, Elevance Health had 5 more articles in the media than Molina Healthcare. MarketBeat recorded 16 mentions for Elevance Health and 11 mentions for Molina Healthcare. Elevance Health's average media sentiment score of 1.60 beat Molina Healthcare's score of 1.10 indicating that Elevance Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Molina Healthcare
9 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Elevance Health
15 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Molina Healthcare currently has a consensus price target of $202.44, indicating a potential upside of 0.97%. Elevance Health has a consensus price target of $440.90, indicating a potential upside of 8.32%. Given Elevance Health's stronger consensus rating and higher probable upside, analysts clearly believe Elevance Health is more favorable than Molina Healthcare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Molina Healthcare
2 Sell rating(s)
12 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.06
Elevance Health
0 Sell rating(s)
8 Hold rating(s)
15 Buy rating(s)
0 Strong Buy rating(s)
2.65

Molina Healthcare has a beta of 0.75, meaning that its stock price is 25% less volatile than the broader market. Comparatively, Elevance Health has a beta of 0.69, meaning that its stock price is 31% less volatile than the broader market.

Summary

Elevance Health beats Molina Healthcare on 13 of the 16 factors compared between the two stocks.

How does Elevance Health compare to UnitedHealth Group?

Elevance Health (NYSE:ELV) and UnitedHealth Group (NYSE:UNH) are both large-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, media sentiment, risk, earnings, institutional ownership, analyst recommendations, valuation and profitability.

Elevance Health has a beta of 0.69, indicating that its stock price is 31% less volatile than the broader market. Comparatively, UnitedHealth Group has a beta of 0.61, indicating that its stock price is 39% less volatile than the broader market.

In the previous week, UnitedHealth Group had 42 more articles in the media than Elevance Health. MarketBeat recorded 58 mentions for UnitedHealth Group and 16 mentions for Elevance Health. Elevance Health's average media sentiment score of 1.60 beat UnitedHealth Group's score of 1.30 indicating that Elevance Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Elevance Health
15 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
UnitedHealth Group
45 Very Positive mention(s)
5 Positive mention(s)
6 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive

Elevance Health presently has a consensus price target of $440.90, suggesting a potential upside of 8.32%. UnitedHealth Group has a consensus price target of $456.56, suggesting a potential upside of 15.06%. Given UnitedHealth Group's stronger consensus rating and higher probable upside, analysts clearly believe UnitedHealth Group is more favorable than Elevance Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Elevance Health
0 Sell rating(s)
8 Hold rating(s)
15 Buy rating(s)
0 Strong Buy rating(s)
2.65
UnitedHealth Group
0 Sell rating(s)
6 Hold rating(s)
19 Buy rating(s)
2 Strong Buy rating(s)
2.85

89.2% of Elevance Health shares are held by institutional investors. Comparatively, 87.9% of UnitedHealth Group shares are held by institutional investors. 0.3% of Elevance Health shares are held by company insiders. Comparatively, 0.2% of UnitedHealth Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Elevance Health pays an annual dividend of $6.88 per share and has a dividend yield of 1.7%. UnitedHealth Group pays an annual dividend of $9.28 per share and has a dividend yield of 2.3%. Elevance Health pays out 30.6% of its earnings in the form of a dividend. UnitedHealth Group pays out 59.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Elevance Health has raised its dividend for 14 consecutive years and UnitedHealth Group has raised its dividend for 15 consecutive years. UnitedHealth Group is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

UnitedHealth Group has a net margin of 3.14% compared to Elevance Health's net margin of 2.47%. UnitedHealth Group's return on equity of 16.53% beat Elevance Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Elevance Health2.47% 14.64% 5.22%
UnitedHealth Group 3.14%16.53%5.43%

UnitedHealth Group has higher revenue and earnings than Elevance Health. Elevance Health is trading at a lower price-to-earnings ratio than UnitedHealth Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Elevance Health$201.11B0.44$5.66B$22.5018.09
UnitedHealth Group$447.57B0.80$12.06B$15.5425.53

Summary

UnitedHealth Group beats Elevance Health on 14 of the 20 factors compared between the two stocks.

How does Elevance Health compare to Humana?

Humana (NYSE:HUM) and Elevance Health (NYSE:ELV) are both large-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, media sentiment, dividends, risk, valuation, profitability and institutional ownership.

Elevance Health has a net margin of 2.47% compared to Humana's net margin of 0.88%. Elevance Health's return on equity of 14.64% beat Humana's return on equity.

Company Net Margins Return on Equity Return on Assets
Humana0.88% 11.20% 3.94%
Elevance Health 2.47%14.64%5.22%

Humana pays an annual dividend of $3.54 per share and has a dividend yield of 0.9%. Elevance Health pays an annual dividend of $6.88 per share and has a dividend yield of 1.7%. Humana pays out 33.5% of its earnings in the form of a dividend. Elevance Health pays out 30.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Elevance Health has raised its dividend for 14 consecutive years. Elevance Health is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

In the previous week, Humana had 14 more articles in the media than Elevance Health. MarketBeat recorded 30 mentions for Humana and 16 mentions for Elevance Health. Elevance Health's average media sentiment score of 1.60 beat Humana's score of 1.05 indicating that Elevance Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Humana
16 Very Positive mention(s)
4 Positive mention(s)
7 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Elevance Health
15 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

92.4% of Humana shares are owned by institutional investors. Comparatively, 89.2% of Elevance Health shares are owned by institutional investors. 0.2% of Humana shares are owned by insiders. Comparatively, 0.3% of Elevance Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Elevance Health has higher revenue and earnings than Humana. Elevance Health is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Humana$145.68B0.33$1.19B$10.5737.91
Elevance Health$201.11B0.44$5.66B$22.5018.09

Humana has a beta of 0.74, meaning that its stock price is 26% less volatile than the broader market. Comparatively, Elevance Health has a beta of 0.69, meaning that its stock price is 31% less volatile than the broader market.

Humana currently has a consensus price target of $403.91, indicating a potential upside of 0.80%. Elevance Health has a consensus price target of $440.90, indicating a potential upside of 8.32%. Given Elevance Health's stronger consensus rating and higher probable upside, analysts clearly believe Elevance Health is more favorable than Humana.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Humana
1 Sell rating(s)
15 Hold rating(s)
14 Buy rating(s)
0 Strong Buy rating(s)
2.43
Elevance Health
0 Sell rating(s)
8 Hold rating(s)
15 Buy rating(s)
0 Strong Buy rating(s)
2.65

Summary

Elevance Health beats Humana on 15 of the 19 factors compared between the two stocks.

How does Elevance Health compare to Oscar Health?

Elevance Health (NYSE:ELV) and Oscar Health (NYSE:OSCR) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, analyst recommendations, earnings, media sentiment, institutional ownership, valuation, profitability and risk.

89.2% of Elevance Health shares are held by institutional investors. Comparatively, 75.7% of Oscar Health shares are held by institutional investors. 0.3% of Elevance Health shares are held by insiders. Comparatively, 22.6% of Oscar Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Elevance Health presently has a consensus price target of $440.90, suggesting a potential upside of 8.32%. Oscar Health has a consensus price target of $26.22, suggesting a potential downside of 18.56%. Given Elevance Health's stronger consensus rating and higher possible upside, equities research analysts clearly believe Elevance Health is more favorable than Oscar Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Elevance Health
0 Sell rating(s)
8 Hold rating(s)
15 Buy rating(s)
0 Strong Buy rating(s)
2.65
Oscar Health
0 Sell rating(s)
8 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.42

Elevance Health has a beta of 0.69, meaning that its share price is 31% less volatile than the broader market. Comparatively, Oscar Health has a beta of 2.37, meaning that its share price is 137% more volatile than the broader market.

Oscar Health has a net margin of 3.60% compared to Elevance Health's net margin of 2.47%. Oscar Health's return on equity of 38.45% beat Elevance Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Elevance Health2.47% 14.64% 5.22%
Oscar Health 3.60%38.45%6.76%

In the previous week, Elevance Health had 7 more articles in the media than Oscar Health. MarketBeat recorded 16 mentions for Elevance Health and 9 mentions for Oscar Health. Elevance Health's average media sentiment score of 1.60 beat Oscar Health's score of 0.70 indicating that Elevance Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Elevance Health
15 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Oscar Health
5 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Elevance Health has higher revenue and earnings than Oscar Health. Elevance Health is trading at a lower price-to-earnings ratio than Oscar Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Elevance Health$201.11B0.44$5.66B$22.5018.09
Oscar Health$11.70B0.85-$443.15M$1.4023.00

Summary

Elevance Health beats Oscar Health on 9 of the 17 factors compared between the two stocks.

Get Elevance Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for ELV and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ELV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ELV vs. The Competition

MetricElevance HealthHealthcare Providers & Services IndustryHealthcare SectorNYSE Exchange
Market Cap$89.95B$10.10B$7.28B$23.69B
Dividend Yield1.70%2.59%2.54%3.72%
P/E Ratio18.0934.60272.4329.32
Price / Sales0.444.90638.1219.90
Price / Cash11.04121.7577.3933.23
Price / Book1.963.9912.857.60
Net Income$5.66B$313.25M$3.48B$1.07B
7 Day Performance2.98%1.06%0.99%-0.05%
1 Month Performance3.97%0.33%5.49%-0.24%
1 Year Performance29.72%15.31%24.34%12.79%

Elevance Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ELV
Elevance Health
4.5976 of 5 stars
$407.05
-1.9%
$440.90
+8.3%
+32.2%$89.95B$201.11B18.0997,100
CNC
Centene
3.7929 of 5 stars
$64.32
-0.7%
$70.05
+8.9%
+133.8%$31.77B$202.94BN/A61,100
MOH
Molina Healthcare
2.4071 of 5 stars
$198.43
-0.8%
$202.44
+2.0%
+17.4%$10.36B$44.52BN/A19,000
UNH
UnitedHealth Group
4.7945 of 5 stars
$389.92
-0.8%
$456.56
+17.1%
+28.0%$349.99B$450.13B25.09390,000
HUM
Humana
4.1731 of 5 stars
$384.25
-0.3%
$403.91
+5.1%
+28.4%$46.14B$129.66B36.3567,060

Related Companies and Tools


This page (NYSE:ELV) was last updated on 9/5/2026 by MarketBeat.com Staff.
From Our Partners